Mercer Global Advisors
TYRA icon

Mercer Global Advisors’s Tyra Biosciences TYRA Stock Holding History

Mercer Global Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.6K Buy
+1,145
New +$37.9K ﹤0.01% 4495

Other funds holding TYRA

APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mercer Global Advisors's TYRA Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Tyra Biosciences (TYRA) in Q2 2026: 1,145 shares worth $36.6K. The stake represents ﹤0.01% of the portfolio and ranks #4495 among its holdings.

142 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Mercer Global Advisors held 1,145 shares of Tyra Biosciences worth $36.6K as of Q2 2026.
  • Tyra Biosciences was a new Mercer Global Advisors position in Q2 2026.
  • Tyra Biosciences made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4495 holding.
  • 142 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.